Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

BUY
$117.13 - $176.59 $127,554 - $192,306
1,089 New
1,089 $156,000
Q1 2022

Apr 07, 2022

SELL
$126.46 - $235.05 $390,634 - $726,069
-3,089 Closed
0 $0
Q4 2021

Jan 18, 2022

SELL
$225.82 - $368.51 $700,945 - $1.14 Million
-3,104 Reduced 50.12%
3,089 $785,000
Q3 2021

Nov 01, 2021

BUY
$221.9 - $484.47 $59,469 - $129,837
268 Added 4.52%
6,193 $2.38 Million
Q2 2021

Aug 06, 2021

BUY
$129.91 - $234.98 $27,151 - $49,110
209 Added 3.66%
5,925 $1.39 Million
Q1 2021

May 03, 2021

BUY
$109.18 - $185.98 $624,072 - $1.06 Million
5,716 New
5,716 $748,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Acg Wealth Portfolio

Follow Acg Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.